481 related articles for article (PubMed ID: 17293067)
21. Thoughts on individualizing hormone replacement therapy based on the postmenopausal health disparities study data.
Gavaler JS
J Womens Health (Larchmt); 2003 Oct; 12(8):757-68. PubMed ID: 14588126
[TBL] [Abstract][Full Text] [Related]
22. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
23. Associations between the use of complementary and alternative medications and demographic, health and lifestyle factors in mid-life Australian women.
Gollschewski S; Anderson D; Skerman H; Lyons-Wall P
Climacteric; 2005 Sep; 8(3):271-8. PubMed ID: 16390759
[TBL] [Abstract][Full Text] [Related]
24. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
Bakken K; Eggen AE; Lund E
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
[TBL] [Abstract][Full Text] [Related]
25. Hormone replacement therapy: attitude and acceptance of Bangkokian women.
Taechakraichana N; Wilawan K; Wipatavit V; Maitrisathit S; Thamanavat N; Jaisamrarn U; Panyakhamlerd K; Havanond P; Limpaphayom KK
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S385-98. PubMed ID: 12930015
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy.
Castelo-Branco C; Blumel JE; Araya H; Riquelme R; Castro G; Haya J; Gramegna G
J Obstet Gynaecol; 2003 Jul; 23(4):426-30. PubMed ID: 12881088
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of and satisfaction with complementary therapies and hormone replacement therapy in a specialist menopause clinic.
Vashisht A; Domoney CL; Cronje W; Studd JW
Climacteric; 2001 Sep; 4(3):250-6. PubMed ID: 11588949
[TBL] [Abstract][Full Text] [Related]
28. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
29. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
[TBL] [Abstract][Full Text] [Related]
30. Menopausal symptoms and knowledge towards daily life and hormone replacement therapy among menopausal women in Bangkok.
Chaopotong P; Titapant V; Boriboonhirunsarn D
J Med Assoc Thai; 2005 Dec; 88(12):1768-74. PubMed ID: 16518972
[TBL] [Abstract][Full Text] [Related]
31. Women's use of hormone replacement therapy for disease prevention; results of a community survey.
Ballard K
Br J Gen Pract; 2002 Oct; 52(483):835-7. PubMed ID: 12392126
[TBL] [Abstract][Full Text] [Related]
32. Determinants of body mass index in women around menopause attending menopause clinics in Italy.
Progetto Menopausa Italia Study Group
Climacteric; 2003 Mar; 6(1):67-74. PubMed ID: 12776693
[TBL] [Abstract][Full Text] [Related]
33. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project.
Lundberg V; Tolonen H; Stegmayr B; Kuulasmaa K; Asplund K;
Maturitas; 2004 May; 48(1):39-49. PubMed ID: 15223107
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy in Denmark, 1995-2004.
Løkkegaard E; Lidegaard O; Møller LN; Agger C; Andreasen AH; Jørgensen T
Acta Obstet Gynecol Scand; 2007; 86(11):1342-51. PubMed ID: 17963062
[TBL] [Abstract][Full Text] [Related]
35. Socio-demographic characteristics of postmenopausal estrogen users.
Strinić T; Buković D; Karelović D; Despot A; Buković N; Giudici E; Silovski H
Coll Antropol; 2002 Jun; 26(1):245-9. PubMed ID: 12137306
[TBL] [Abstract][Full Text] [Related]
36. Menopause characteristics of women with physical disabilities from poliomyelitis.
Kalpakjian CZ; Quint EH; Tate DG; Roller S; Toussaint LL
Maturitas; 2007 Feb; 56(2):161-72. PubMed ID: 16930875
[TBL] [Abstract][Full Text] [Related]
37. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe.
Schneider HP
Int J Fertil Womens Med; 1997; 42 Suppl 2():365-75. PubMed ID: 9397384
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy and health behavior in postmenopausal polio survivors.
Kalpakjian CZ; Riley BB; Quint EH; Tate DG
Maturitas; 2004 Aug; 48(4):398-410. PubMed ID: 15283932
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with intention to use hormone replacement therapy among Thai middle-aged women.
Burusanont M; Hadsall RS
Maturitas; 2004 Mar; 47(3):219-27. PubMed ID: 15036492
[TBL] [Abstract][Full Text] [Related]
40. Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.
Wise MR; Stewart DE; Liu P; Abramson BL
CMAJ; 1999 Jul; 161(1):33-6. PubMed ID: 10420861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]